Your Outpatient has Coronavirus Disease 2019: What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate?

Mutations accumulated by novel Severe Acute Respiratory Syndrome Coronavirus 2 Omicron sublineages contribute to evasion of previously effective monoclonal antibodies for treatment or prevention of Coronavirus Disease 2019 (COVID-19). Other authorized or approved antiviral drugs such as nirmatrelvir...

Descripción completa

Detalles Bibliográficos
Autores principales: Werbel, William A, Weld, Ethel D, Advani, Sonali D, Patel, Payal K, Sundaram, Maria E, Phadke, Varun K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Viewpoints Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320072/
https://www.ncbi.nlm.nih.gov/pubmed/36999905
http://dx.doi.org/10.1093/cid/ciad178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320072/
https://www.ncbi.nlm.nih.gov/pubmed/36999905
http://dx.doi.org/10.1093/cid/ciad178

Ejemplares similares